血糖采血针市场:现状分析与预测(2022-2030年)

血糖刺血针市场保持稳定在5%左右，因为刺血针技术的进步，例如无痛超薄刺血针的开创性，显着提高了患者的舒适度和依从性，推动市场需求预计增长。此外，扩大采用自我护理管理方法和家庭血糖监测设备也有助于市场增长。

为了更好地了解血糖采血针行业的市场介绍，将市场分为北美（美国、加拿大、北美其他地区）、欧洲（德国、英国、法国、西班牙、意大利、欧洲其他地区） ）、亚太地区（中国、日本、欧洲其他地区）、印度、亚太地区其他地区）以及世界其他地区（基于其在各国的全球影响力）。北美在 2021 年占据主导地位。这主要是由于久坐的生活方式、不健康的饮食习惯和遗传倾嚮导致该地区大量人被诊断患有糖尿病。这大大增加了对糖尿病定期监测和管理的血糖采血针的需求。此外，该地区拥有发达的医疗基础设施、对糖尿病管理的高度认识以及不断增加的糖尿病患病率持续推动市场增长。例如，根据国际糖尿病联盟第 10 版糖尿病图谱，到 2021 年，美国将有大约 3220 万人患有糖尿病，预计到 2045 年，这一数字将增至 3630 万人。

目录

第1章 市场简介

• 市场定义
• 主要目的
• 相关利益者
• 限制事项

第2章 调查手法或前提

• 调查流程
• 调查手法
• 受访者简介

第3章 市场概要

第4章 摘要整理

第5章 COVID-19对血糖采血针市场带来的影响

第6章 血糖采血针的市场收益，2020-2030年

第7章 市场洞察:各类型

• Push Button Lancet
• Pressure Activated Lancet
• Side Activated Lancet

第8章 市场洞察:各终端用户

• 患者/居家医疗
• 医院和诊所

第9章 市场洞察:各地区

• 北美
  • 美国
  • 加拿大
  • 其他北美地区
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 全球其他地区

第10章 血糖采血针市场动态

• 推动市场要素
• 市场课题
• 影响分析

第11章 血糖采血针市场机会

第12章 血糖采血针市场趋势

第13章 需求面和供给面的分析

• 需求面分析
• 供给面分析

第14章 价值链分析

第15章 价格分析

第16章 策略性洞察能力

第17章 竞争模式

• 竞争情形
  • 波特的五力分析

第18章 企业简介

• LifeScan IP Holdings, LLC
• DarioHealth Corp
• Beurer GmbH
• BD
• MEDISANA GMBH
• Dexcom, Inc.
• Abbott
• AgaMatrix
• Medtronic
• F. Hoffmann-La Roche Ltd

第19章 免责声明

Blood glucose lancets are small, disposable medical devices used to prick the skin and obtain a small drop of blood for glucose testing. The market for blood glucose lancets is experiencing robust growth and is expected to continue expanding in the coming years due to the rising prevalence of diabetes and obesity. For instance, the World Obesity Federation predicts that by 2030, one in five women and one in seven men will have obesity. Also, with sedentary lifestyles, unhealthy eating habits, and an aging population, the number of individuals diagnosed with diabetes has been steadily increasing. This has resulted in a higher demand for lancets used for blood glucose monitoring. Moreover, the growing awareness among patients about the significance of regular blood glucose testing for effective diabetes management has further fueled market growth.

The blood glucose lancets market is expected to grow at a steady rate of around 5% owing to the advancements in lancet technology, including the development of painless and ultra-thin lancets, which have significantly improved patient comfort and compliance, thereby driving market demand. Furthermore, the increasing adoption of self-care management approaches and home-based glucose monitoring devices has contributed to the market's growth.

Based on type, the market is segmented into push button lancet, pressure activated lancet, and side activated lancet. Among them, the push button lancet category is to witness higher CAGR during the forecast period owing to these lancets making the process of obtaining a blood sample less painful and more convenient, which has increased patient compliance with glucose testing. Also, push button lancets have made glucose testing more accessible to a wider range of individuals, including those who may have difficulty using traditional lancing devices. This has expanded the market for blood glucose lancets.

Based on end-user, the blood glucose lancets market has been bifurcated into patients/homecare and hospitals & clinics. The hospitals & clinics category is to witness higher adoption of blood glucose lancets during the forecast period. This is mainly due to the large number of diabetic patients who require blood testing kits and the rising prevalence of infectious diseases. For example, as per the International Diabetes Federation (IDF), around 1.2 million youngsters and youths have type 1 diabetes in 2021. Additionally, homecare diagnostic testing generates more revenue for the market because it is more expensive in the hospital.

For a better understanding of the market adoption of the blood glucose lancets industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America dominated the market in 2021. This is mainly due to the region having a considerable number of individuals diagnosed with diabetes, primarily due to sedentary lifestyles, unhealthy eating habits, and genetic predisposition. This has resulted in a substantial demand for blood glucose lancets for regular monitoring and management of diabetes. Additionally, the region has a well-developed healthcare infrastructure, a high level of awareness regarding diabetes management, and a growing prevalence of diabetes which will drive the growth of the market consistently. For instance, according to the International Diabetes Federation Diabetes Atlas Tenth edition, in 2021, around 32.2 million people in the United States had diabetes, projected to grow to 36.3 million by 2045.

Some of the major players operating in the market include: LifeScan IP Holdings, LLC; DarioHealth Corp; Beurer GmbH; BD; MEDISANA GMBH; Dexcom, Inc.; Abbott; AgaMatrix; Medtronic; and F. Hoffmann-La Roche Ltd.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Main Objective
• 1.3. Stakeholders
• 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Blood Glucose Lancets Market
• 2.2. Research Methodology of the Blood Glucose Lancets Market
• 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE BLOOD GLUCOSE LANCETS MARKET

6 BLOOD GLUCOSE LANCETS MARKET REVENUE, 2020-2030F

7 MARKET INSIGHTS BY TYPE

• 7.1. Push Button Lancet
• 7.2. Pressure Activated Lancet
• 7.3. Side Activated Lancet

8 MARKET INSIGHTS BY END-USER

• 8.1. Patients/Homecare
• 8.2. Hospitals & Clinics

9 MARKET INSIGHTS BY REGION

• 9.1. North America
  • 9.1.1. U.S.
  • 9.1.2. Canada
  • 9.1.3. Rest of North America
• 9.2. Europe
  • 9.2.1. Germany
  • 9.2.2. U.K.
  • 9.2.3. France
  • 9.2.4. Italy
  • 9.2.5. Spain
  • 9.2.6. Rest of Europe
• 9.3. Asia-Pacific
  • 9.3.1. China
  • 9.3.2. Japan
  • 9.3.3. India
  • 9.3.4. Rest of Asia-Pacific
• 9.4. Rest of World

10 BLOOD GLUCOSE LANCETS MARKET DYNAMICS

• 10.1. Market Drivers
• 10.2. Market Challenges
• 10.3. Impact Analysis

11 BLOOD GLUCOSE LANCETS MARKET OPPORTUNITIES

12 BLOOD GLUCOSE LANCETS MARKET TRENDS

13 DEMAND AND SUPPLY-SIDE ANALYSIS

• 13.1. Demand Side Analysis
• 13.2. Supply Side Analysis

14 VALUE CHAIN ANALYSIS

15 PRICING ANALYSIS

16 STRATEGIC INSIGHTS

17 COMPETITIVE SCENARIO

• 17.1. Competitive Landscape
  • 17.1.1. Porters Fiver Forces Analysis

18 COMPANY PROFILED

• 18.1. LifeScan IP Holdings, LLC
• 18.2. DarioHealth Corp
• 18.3. Beurer GmbH
• 18.4. BD
• 18.5. MEDISANA GMBH
• 18.6. Dexcom, Inc.
• 18.7. Abbott
• 18.8. AgaMatrix
• 18.9. Medtronic
• 18.10. F. Hoffmann-La Roche Ltd

19 DISCLAIMER